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Population—Is it a Risk Factor for Sudden Death?
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Background: People receive electrocardiogram (ECG) examination for various reasons in a hospital setting.
An important clinical practice issue may be that cardiologists need to be consulted for Brugada-type ECGs
identified through routine screening. We investigated the prevalence and prognosis of patients with Brugada-
type ECG in a hospital-based population in an attempt to improve the management of these patients.
Methods: In 20,562 patients seeking medical care for non-cardiovascular reasons, 74,955 ECGs were per-
formed from December 1999 to February 2001. The diagnostic criteria for Brugada-like ECG from the
European Society of Cardiology were used. International Statistical Classification of Diseases codes and city
residents’ records were documented to indicate the reasons for visiting clinics or hospitalization and mortality
outcome. Medical records were reviewed and telephone interviews were conducted.
Results: Twenty-six (0.13%) of the 20,562 patients were confirmed to have Brugada-type ECGs. None of
these patients had ever experienced syncope, near syncope or sudden cardiac death. After 57.1 ± 15.8 months
of follow-up, there were four deaths out of the 26 patients with Brugada-type ECG (15.4%, 95% CI:
1.53–2.9%) compared with 2899 of those without (14.1%, 95% CI: 13.6–14.5%; p = 0.89, log-rank test).
Neither sudden cardiac death (p = 0.61) nor hospitalized death (p = 0.55) was different between patients
with and without Brugada-type ECG.
Conclusion: Patients with Brugada-type ECGs are not rare in a hospital-based population. The presence of
Brugada-type ECGs in patients without syncope or sudden cardiac death was not associated with hospitalized
mortality.
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In 1992, Brugada and Brugada first reported a spe-
cific clinical entity of idiopathic ventricular fibril-
lation (VF) presenting with ST segment elevation
in leads V1–V3, with or without right bundle
branch block, and normal QT interval in the ab-
sence of structural heart disease or other reversible
causes.1 Such patients die suddenly of VF, often
in their sleep. Epidemiologic studies suggest that
the disease might be responsible for nearly half of
all sudden cardiac deaths in individuals without
structural heart disease.2 This disease is the most
common cause of sudden cardiac death in young
persons in South Asia.3 Previous reports in small
hospital-based populations demonstrated the an-
nual risk for fatal arrhythmia to be 11–38% in pa-
tients diagnosed with the Brugada syndrome with
clinical manifestation of syncope, near syncope or
sudden death. However, information regarding the
prevalence and the long-term prognosis of non-
cardiovascular patients with Brugada-type elec-
trocardiogram (ECG; identified through routine
screening) in a hospital population remains very
limited. The uncertainty between apparent “phe-
notype” and the risk of unexpected mortality
could cause a decision-making dilemma in clini-
cal practice.
Patients and Methods
Subjects and ECG interpretation
Patients who had ECGs recorded during outpa-
tient clinic visits or hospital admission in a terti-
ary medical center between December 1999 and
February 2001 in Taiwan were included. A total of
74,955 ECGs were performed consecutively on
20,562 patients seeking medical care for non-
cardiovascular reasons, including 5,752 men and
14,810 women during the study period. All ECGs
were recorded at a standard gain (1 mV/10 mm)
and paper speed (25 mm/s), and digitized at 500
samples/second by a computerized cardiograph
(Hewlett Packard, USA). A commercially-available
12-lead ECG analysis program (Agilent Technol-
ogy, Massachusetts–Andover, USA) was applied
for initial screening of ECGs characterized as
“complete right bundle branch block (RBBB)”,
“incomplete RBBB”, “RsR’ in V1” or “any kind of
ST elevation or ST & T wave abnormality”. The se-
lected ECGs were reconfirmed by two cardiologists
without knowledge of the patients’ demographic
characteristics. The diagnoses of Brugada-type ECG
were performed by three other independent cardi-
ologists according to the new criteria proposed by
the European Society of Cardiology. Consensus
was achieved whenever discordant interpretations
emerged.
The ICD-9 CM (International Statistical Clas-
sification of Diseases) codes for the indication and
underlying disease of all patients participating in
the study during hospital visits had been previ-
ously documented. For patients with Brugada-type
ECGs, comprehensive medical records including
personal history of syncope, near syncope, sud-
den death of all causes, as well as family history
of similar symptoms and cardiovascular diseases
were reviewed and confirmed through telephone
interviews.
Definition of Brugada-type ECG
An ECG was classified as a Brugada-type ECG if
any of the following criteria were met: (1) type I
was defined if prominent cove-shaped ST-T seg-
ment with a J wave amplitude or ST-segment ele-
vation ≥ 2 mm (i.e. 0.2 mV) at its peak followed
by a negative T-wave, with little or no isoelectric
separation; (2) type II was defined if high take-off
ST segment and a J wave amplitude ≥ 2 mm with
gradually decreasing ST-segment elevation (remain-
ing ≥ 1 mm above the baseline), followed by a
positive or biphasic T-wave that gives rise to sad-
dle back configuration; (3) type III was defined if
right precordial ST-segment elevation, < 1 mm, of
a saddle back type, coved type, or both.4 Figure 1
shows three Brugada-type ECGs from the present
study representing each of the above mentioned
criteria.
Definition of sudden cardiac death and
hospitalized death
Information on the cause of death was obtained
from death certificates. We defined sudden cardiac
J.M.J. Juang, et al
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death as death occurring out of hospital or death
in the emergency room, or “dead on arrival” with
an underlying cardiac disease (ICD-9 CM 390 to
398, 402, or 404 to 429). Deaths occurring in the
hospital were surveyed and defined as hospital-
ized deaths.
Statistical analysis
All continuous data were expressed as mean± stan-
dard deviation. The differences between two in-
dependent variables were analyzed by unpaired
Student t test. A frequency comparison was per-
formed using χ2 test. Confidence interval (CI) of
the binominal distribution for prevalence rates
was calculated. Inter-observer agreement was de-
termined by overall proportion of agreements
and by using the Kappa statistic. The probability
of survival was estimated by the Kaplan-Meier
method, and the log-rank test was used for the
comparison of the difference in mortality between
patients with and without the Brugada-type ECG.
A two-tailed p < 0.05 was considered to indicate
significance.
Results
Our study population consisted of 20,562 patients
with a mean age of 49 ± 21 years (range, 0–104
years). About 38.8% of the population were male
(n = 7978). The demographic characteristics of the 
26 patients with Brugada-type ECG and 20,536
patients without are listed in Table 1. The age dis-
tribution of all patients is shown in Figure 2.
There is no statistically significant difference be-
tween the mean age and gender of patients with
Brugada-type ECG and those without. No cases
with Brugada syndrome were diagnosed during
the study period.
Clinical demographic results of ICD codes
The distribution of ICD codes for patients with
Brugada-type ECGs and those without are shown
in Table 2. The ICD code “other form of heart dis-
ease” was used to code all kinds of arrhythmias.
This showed that 97% of the ICD codes were not
associated with other forms of heart disease in
both groups and suggests that the disease pattern
of this hospital-based population was mostly not
related to arrhythmias. Furthermore, there is no
significant difference in the percentage of codes
related to arrhythmia between the two groups.
Prevalence of patients with Brugada-type
ECG in a hospital population
A total of 74,955 ECGs performed on 20,562 pa-
tients were screened by the 12-lead ECG analysis
program. Two cardiologists confirmed the iden-
tification of complete RBBB in the ECGs of 553
patients, incomplete RBBB in 281 patients, variant
ST elevation in 159 patients and RsR’ in V1 pattern
in 93 patients. The prevalence of complete RBBB
was 2.7% (95% CI, 2.5–2.9%) and that of incom-
plete RBBB was 1.4% (95% CI, 1.2–1.6%). Overall,
26 patients (11 male and 15 female; 0.13%, 95%
CI, 0.08–0.18%) were confirmed in consensus to
V1
V2
V3
V1
V2
V3
V1
V2
V3
Figure 1. Examples of three patterns of Brugada-type
ECGs from our patients.
Table 1. Demographic data of patients with and
without Brugada-type ECG
With Without 
Brugada-type Brugada-type p
ECG ECG
Mean 56 ± 17 49 ± 20 0.12
age±SD (yr)
Gender (M:F) 11:15 7967:12569 0.10
ECG = electrocardiogram; SD = standard deviation.
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have Brugada-type ECGs and structurally normal
hearts. The prevalence of Brugada-type ECG in
males is higher than that in females (0.19% vs.
0.1%). The overall proportion of agreement in the
diagnosis of Brugada-type ECG among the three
interpreters was 99.7% with a Kappa score of 0.95.
As shown in Table 1, there was neither signifi-
cant gender dominance nor any significant differ-
ence in the mean ages of the two groups. However,
the prevalence of patients with the Brugada-type
ECG was higher than that of those without (42%
vs. 28%) in males. Among the 26 patients with
Brugada-type ECGs, type I Brugada ECG was noted
in one patient, type II in 16 patients and type III in
nine patients. The clinical history, family history
and ECG characteristics of these patients are listed
in Table 3. No history of syncope, near syncope,
seizure or resuscitated sudden death was recorded
in medical records for all 26 patients. The only sub-
ject with type I Brugada ECG was a 38-year-old
woman hospitalized for gallstone-related acute
cholecystitis and later laparoscopic cholecystec-
tomy. Two other patients (with type II & type III
Brugada-type ECG, respectively) had experienced
the sudden death of a family member.
Clinical prognosis of patients with 
Brugada-type ECG
During the clinical follow-up period for patients
with Brugada-type ECGs, 57.1 ± 15.8 months, four
patient deaths occurred (15.4%; 95% CI: 1.53–
2.9%). The follow-up period for the patients
4500
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Figure 2. Age distribution of all study subjects.
Table 2. The distribution of International classification of diseases codes among patients with and without
Brugada-type ECG
ICD code
With Brugada-type Without Brugada-type 
p
ECG (n = 131) ECG (n = 106,794)
Disease of the 001–389, 460–999, 107 (81.68) 90,551 (84.79) 0.32
non-circulatory systems E800–E999, V01–V82
Disease of the 390–459 24 (18.32) 16,243 (15.21)
circulatory system
Arrhythmia-related 420–429 4 (3.05) 3083 (2.89) 0.77
ECG = electrocardiogram; ICD = International classification of diseases.
J.M.J. Juang, et al
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without Brugada-type ECGs was 58.4 ± 14.8
months and 2899 patient deaths (14.1%; 95%
CI, 13.6–14.5%) occurred. Two of the four de-
ceased patients with Brugada-type ECGs died of
infection. The remaining two died of acute renal
failure and malignancy, respectively. None of the
four all-cause deaths in the patients with Brugada-
type ECGs were cardiovascular deaths. Three of
the four deceased patients with Brugada-type
ECGs died in hospital, whereas 207 deceased pa-
tients without Brugada-type ECGs died as a result
of cardiovascular deaths and 1608 were hospital-
ized deaths. No unexpected deaths were docu-
mented in patients with Brugada-type ECGs, but
22 unexpected deaths were documented in pa-
tients without Brugada-type ECGs. The log-rank
test revealed no differences in all-cause (p=0.89),
cardiovascular (p = 0.61), hospitalized deaths 
(p = 0.55) and all-unexpected deaths (p = 0.85)
between patients with Brugada-type ECGs and
those without (Figures 3 and 4).
Discussion
In the 1980s, the Centers for Disease Control
(CDC) in Atlanta, Georgia, reported an abnormally
high incidence of sudden death in young immi-
grants from Southeast Asia.3 In 1992, Pedro and
Josep Brugada originally described the syndrome
with a special ECG pattern, consisting of RBBB and
at least 1 mm of ST segment elevation in leads
Table 3. Clinical characteristics of patients with Brugada-type ECGs
Characteristics Type I (n = 1) Type II (n = 16) Type III (n = 9) Total (n = 26)
Female 1 8 6 15
Male 0 8 3 11
Mean age ± SD (yr) 38 55 ± 19 63 ± 14 57 ± 18
Syncope or seizure 0 0 0 0
Sudden cardiac death 0 0 0 0
Familiar sudden death or syncope 0 1 1 2
RsR’ in V1 0 1 0 1
ICRBBB 1 13 4 18
ST elevation 0 1 0 1
CRBBB 0 1 5 6
SD = standard deviation; ICRBBB = incomplete right bundle branch block; CRBBB = complete right bundle branch block.
Figure 3. Kaplan-Meier survival analysis from (A) all cause mortality and (B) all sudden cardiovascular death between
subjects with and without Brugada-type ECG. Log-rank, p = 0.89 and 0.61, respectively.
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V1–V3 in association with sudden cardiac death.1
Although this syndrome is observed worldwide
and the exact prevalence is unknown, it is more
common in Southeast Asian countries. This is the
first study on the prevalence and clinical progno-
sis of the Brugada-type ECGs in the Chinese Han
hospital-based population.
Prevalence of ECG abnormalities
The prevalence of complete RBBB is 2.7%, and that
of incomplete RBBB is 1.4%, in our study. The val-
ues are comparable with those reported by Atarashi
et al (2.2% and 1.7%, respectively ) and Katz and
Pick (2.3% and 1.1%, respectively).5,6 In France,
it has also been reported that the population-
based prevalence of isolated, complete RBBB was
in the range of only 0.18–0.35%.7 Gussak et al
reported that the presence of complete RBBB is
not thought to be essential for the diagnosis of
the Brugada-type ECG, as about one-third of the
reported cases did not fit into this criterion.8
Data obtained from our study also supports this
idea as only six of the 26 patients (0.23%) with
Brugada-type ECG have complete RBBB.
Studies have suggested that different popula-
tions from different countries or even different
areas in one country have different reported preva-
lence of Brugada-type ECGs. In Japan, Tohyou 
et al reported a 0.05% prevalence of abnormal
ECG compatible with this syndrome in an adult
population of 22,027 subjects.9 While Atarashi
et al reported that the prevalence of a Brugada-
type ECG abnormality in working Japanese adults
is 0.16%,10 Miyasaka et al found Brugada-type
ECGs in 98 of 13,929 study subjects (0.7%).11 In
Thailand, the incidence of sudden unexpected
nocturnal death (SUND) has been estimated to
be between 26–38 cases per 100,000 inhabitants
per year; and in Laos, it may cause one sudden
death per 1000 inhabitants per year.12 Between
6–32 cases of SUND a year has been recorded
among Thai construction workers in Singapore,
with a total of 161 deaths between 1982 and
1990.13 In France, Hermida et al reported a 6.1%
prevalence of Brugada-type ECG in an apparently
healthy population.7 In the United States, Monroe
et al reported that a total of 52 Brugada-type ECGs
from approximately 12,000 patients (0.43%) were
identified in North Carolina.14 In New Orleans,
Greer et al disclosed that only 18 coved-type
Brugada ECGs were verified in 27,328 patients.15
In this study, we found a 0.13% prevalence of the
Brugada-type ECG in 20,562 Chinese Han patients
in Taiwan. This result was similar to that conducted
in a population in Tokyo and Asahikawa in
Japan.17,28 We have listed the results of different
populations in Table 4.7,10,11,14−18,27,28
The reported prevalence of this ECG abnor-
mality has varied widely in the above-mentioned
countries. The variations in these studies may not
Figure 4. Kaplan-Meier survival analysis from (A) all in hospital mortality and (B) unexplained accidental mortality 
between subjects with and without Brugada-type ECG. Log-rank, p = 0.89 and 0.61, respectively.
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only have been due to differences in subjects or the
racial population examined, but also due to the
differences in definitions of a Brugada-type ECG.
Previous reported studies in different populations
mostly used the definition of “RBBB and coved or
saddleback type ST-segment elevation (an eleva-
tion of J point of at least 0.1 mV in leads V1–V3)”.
In this study, we used the criteria proposed by
the European Society of Cardiology for the three
different types of ST-segment abnormalities in
Brugada-type ECGs. All of the three types of
Brugada-type ECGs should have an elevation of
the J point of at least 0.2 mV in leads V1–V3 in-
dependent of the type of ST-T configuration dis-
play.4 If we applied at least 0.1 mV of elevation at
J point in leads V1–V3 as one of the criteria, an
additional 36 patients would have been included
in the study. Moreover, we also excluded patients
with a Brugada-type ECG with any structural heart
disease. Due to the dynamic pattern property of
Brugada-type ECGs, we could not accurately elu-
cidate the actual prevalence of the Brugada-type
ECG, and may have underestimated it. As a result,
our prevalence of the Brugada-type ECG was rel-
atively lower than that in other populations al-
though our study population was located in an
endemic area. However, Greer et al reported that
if these new proposed criteria were applied to the
27,328 patients in their study (most of them being
African American), no patients’ ECG fulfilled the
current criteria for Brugada-type ECG.15 In rela-
tion to this, we suggest that the prevalence of the
Brugada-type ECG in our study population may
be higher than that in the African American pop-
ulation (0.13% vs. 0.07%).
Prognosis of the Brugada-type ECG
Previous hospital-based studies demonstrated that
patients with Brugada-type ECGs were at a high risk
of sudden death events, at 11–38% annually.3,19,20
However, the scales of these studies were small,
with sample size ranging from 27 to 63. All sub-
jects in these studies had either Brugada-type ECGs
or a history of sudden unexpected death. To the
best of our knowledge, no study to date has eval-
uated whether this ECG pattern was associatedT
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with an increased mortality in a hospital-based
population of this number.
We ascertained information on the cause of
death in all-deceased patients from death certifi-
cates. All-cause mortality, all sudden cardiovascu-
lar deaths, or all hospitalized deaths in patients
with Brugada-type ECGs did not statistically dif-
fer from those without (Figures 3 and 4). Priori
et al reported that asymptomatic patients with
Brugada-type ECGs were at a lower risk for sud-
den death during a mean follow-up of 33 ± 38
months,21 but for 14% of asymptomatic patients,
cardiac events had occurred at the 34 ± 44 month
follow-up.22 Relatively benign clinical courses in
asymptomatic patients with the Brugada-type ECG
without a family history of sudden death were
also shown in the study by Takenaka et al,23 and
Wilde et al24 The results of our study were consis-
tent with these observations.
Limitations
Limitations of this study include inability to apply
these findings outside of a hospital-based popu-
lation. However, it is worth mentioning that rou-
tine ECG screening is rarely conducted out of the
hospital setting, except for specific study purposes.
The authors therefore feel that limiting the study
population to that which is hospital based reflects
the actual situation in clinical practice more ac-
curately than would a general population.
Another limitation to this study is that the
prevalence of Brugada-type ECG in this study may
be under-estimated based on the detection of one-
strip ECG because of a very high percentage of
dynamic pattern property of Brugada-type ECGs.
Another limitation may have been the result of
our female dominant study population. As only
38.8% of the study population were male, our
result of a higher but non-significant difference
in males compared to females in terms of the
prevalence of the Brugada-type ECG may have
been affected by this. This may explain why our
results are different form that found by Atarashi
et al and Miyasaka et al. However, such a female
dominant study population is not uncommon in
clinical practice. Galdas and colleagues25 reviewed
key research literature on men’s health-related
help seeking behavior and found that men are
less likely than women to seek help from health
professionals for a variety of problems ranging
from depression to physical disabilities and stress-
ful life events. This is also supported by Tudiver
and colleagues26 who suggested a tendency for
men to underuse primary care health services 
despite their susceptibility to particular types of
illness. Considering the difference between gen-
ders in terms of healthcare seeking behavior, our
female dominant study population may reflect
more accurately the situation found in clinical
practice.
From our results, we assumed that the presence
of Brugada-type ECGs may not increase mortality
in general hospital-based populations, and thus
may not be the main risk factor. However, rou-
tine follow-up is strongly suggested even if the
patients are asymptomatic with the absence of a
family history of sudden death, syncope or the
Brugada syndrome.
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